Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension

Pharmacology and Therapeutics

Volumn 138, Issue 3, 2013, Pages 409-417

  Thomas, Matthew ^a   Ciuclan, Loredana ^a   Hussey, Martin J ^a   Press, Neil J ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Disease mechanisms; Pulmonary arterial hypertension; Serotonin; Therapies

Indexed keywords

ANOREXIGENIC AGENT; PLATELET DERIVED GROWTH FACTOR; RHO FACTOR; RHOK PROTEIN; SEROTONIN; UNCLASSIFIED DRUG;

CELL PROLIFERATION; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATION; LUNG FIBROSIS; LUNG VASCULAR RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; THROMBOSIS;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; SEROTONIN;

EID: 84877584950     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.02.002     Document Type: Review

References (96)

1. K. Abe, M. Toba, A. Alzoubi, M. Ito, K.A. Fagan, and C.D. Cool Formation of plexiform lesions in experimental severe pulmonary arterial hypertension Circulation 121 2010 2747 2754
2. S. Abid, A. Houssaini, C. Chevarin, E. Marcos, C.M. Tissot, and G. Gary-Bobo Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice Am J Physiol Lung Cell Mol Physiol 303 6 2012, Sep 15 L500 L508
3. E.D. Austin, J.D. Cogan, J.D. West, L.K. Hedges, R. Hamid, and E.P. Dawson Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females Eur Respir J 34 2009 1093 1099
4. L. Beretta, M. Cossu, M. Marchini, F. Cappiello, A. Artoni, and G. Motta A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation Arthritis Res Ther 10 2008
5. M. Berger, J.A. Gray, and B.L. Roth The expanded biology of serotonin Annu Rev Med 60 2009 355 366
6. V.J. Burton, L.I. Ciuclan, A.M. Holmes, D.M. Rodman, C. Walker, and D.C. Budd Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function Blood 117 1 2011, Jan 6 333 341
7. L. Ciuclan, O. Bonneau, M. Hussey, N. Duggan, A.M. Holmes, and R. Good A novel murine model of severe pulmonary arterial hypertension Am J Respir Crit Care Med 184 2011 1171 1182
8. L. Ciuclan, M.J. Hussey, V. Burton, R. Good, N. Duggan, and S. Beach Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression Am J Respir Crit Care Med 187 1 2013, Jan 1 78 89
9. clinical trials.gov. Information from clinical trials.gov'.; 2008. Ref Type: Online Source.
10. N. Cloutier, A. Paré, R.W. Farndale, H.R. Schumacher, P.A. Nigrovic, and S. Lacroix Platelets can enhance vascular permeability Blood 120 6 2012, Aug 9 1334 1343
11. A. Cogolludo, L. Moreno, F. Lodi, G. Frazziano, L. Cobeno, and J. Tamargo Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells - role of 5-HT2A receptors, caveolin-1, and K(V)1.5 channel internalization Circ Res 98 2006 931 938
12. R.J. Davies, A.M. Holmes, J. Deighton, L. Long, X.D. Yang, and L. Barker BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines Am J Physiol Lung Cell Mol Physiol 302 2012 L604 L615
13. R.J. Davies, and N.W. Morrell Molecular mechanisms of pulmonary arterial hypertension role of mutations in the bone morphogenetic protein type II receptor Chest 134 2008 1271 1277
14. C. Dees, A. Akhmetshina, P. Zerr, N. Reich, K. Palumbo, and A. Horn Platelet-derived serotonin links vascular disease and tissue fibrosis J Exp Med 208 2011 961 972
15. Y. Dempsie, and M.R. MacLean Pulmonary hypertension: therapeutic targets within the serotonin system Br J Pharmacol 155 2008 455 462
16. Y. Dempsie, I. Morecroft, D.J. Welsh, N.A. MacRitchie, N. Herold, and L. Loughlin Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice Circulation 117 2008 2928 2937
17. Y. Dempsie, M. Nilsen, K. White, K.M. Mair, L. Loughlin, and N. Ambartsumian Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females Respir Res 12 2011
18. J.I. Drake, H.J. Bogaard, S. Mizuno, B. Clifton, B. Xie, and Y. Gao Molecular signature of a right heart failure program in chronic severe pulmonary hypertension Am J Respir Cell Mol Biol 45 2011 1239 1247
19. R. Dumitrascu, C. Kulcke, M. Konigshoff, F. Kouri, X. Yang, and N. Morrell Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats Eur Respir J 37 2011 1104 1118
20. S. Eddahibi, and S. Adnot Serotonin and pulmonary arterial hypertension Rev Mal Respir 23 2006 S45 S51
21. S. Eddahibi, C. Guignabert, A.M. Barlier-Mur, L. Dewachter, E. Fadel, and P. Dartevelle Cross talk between endothelial and smooth muscle cells in pulmonary hypertension - critical role for serotonin-induced smooth muscle hyperplasia Circulation 113 2006 1857 1864
22. A.J. Edgar, M.R. Chacon, A.E. Bishop, M.H. Yacoub, and J.M. Polak Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension Respir Res 7 2006
23. P. Egermayer, G.I. Town, and A.J. Peacock Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax 54 1999 161 168
24. K. Engelman, W. Lovenber, and M.A. Sjoerds Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with carcinoid syndrome N Engl J Med 277 1967 1103 (-&)
25. M.G. Frid, J.A. Brunetti, D.L. Burke, T.C. Carpenter, N.J. Davie, and J.T. Reeves Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage Am J Pathol 168 2006 659 669
26. W.H. Frishman, S. Huberfeld, S. Okin, Y.H. Wang, A. Kumar, and B. Shareef Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease J Clin Pharmacol 35 1995 541 572
27. S. Gairhe, N.N. Bauer, S.A. Gebb, and I.F. McMurtry Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells Am J Physiol Lung Cell Mol Physiol 301 2011 L527 L535
28. H.A. Ghofrani, N.W. Morrell, M.M. Hoeper, H. Olschewski, A.J. Peacock, and R.J. Barst Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy Am J Respir Crit Care Med 182 2010 1171 1177
29. C. Guignabert, B. Raffestin, R. Benferhat, W. Raoul, P. Zadigue, and D. Rideau Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats Circulation 111 2005 2812 2819
30. C. Guilluy, S. Eddahibi, C. Agard, C. Guignabert, M. Izikki, and L. Tu RhoA and Rho kinase activation in human pulmonary hypertension role of 5-HT signaling Am J Respir Crit Care Med 179 2009 1151 1158
31. I.H. Hanna, S. Dawling, N. Roodi, F.P. Guengerich, and F.F. Parl Cytochrome P4501B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity Cancer Res 60 2000 3440 3444
32. P. Herve, J.M. Launay, M.L. Scrobohaci, F. Brenot, G. Simonneau, and P. Petitpretz Increased plasma serotonin in primary pulmonary-hypertension Am J Med 99 1995 249 254
33. K.H. Hong, Y.J. Lee, E. Lee, S.O. Park, C. Han, and H. Beppu Genetic ablation of the Bmpr2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension Circulation 118 2008 722 730
34. S.E. Hufton, I.G. Jennings, and R.G.H. Cotton Structure and function of the aromatic amino-acid hydroxylases Biochem J 311 1995 353 366
35. M. Humbert, N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, and I.M. Lang Cellular and molecular pathobiology of pulmonary arterial hypertension J Am Coll Cardiol 43 2004 13S 24S
36. K.S. Hunter, P.F. Lee, C.J. Lanning, D.D. Ivy, K.S. Kirby, and L.R. Claussen Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension Am Heart J 155 2008 166 174
37. J.D. Hutcheson, V. Setola, B.L. Roth, and W.D. Merryman Serotonin receptors and heart valve disease - it was meant 2B Pharmacol Ther 132 2011 146 157
38. F. Jaffre, P. Bonnin, J. Callebert, H. Debbabi, V. Setola, and S. Doly Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy Circ Res 104 2009 113 123
39. Y. Kanai, S. Hori, T. Tanaka, M. Yasuoka, K. Watanabe, and N. Aikawa Role of 5-hydroxytryptamine in the progression of monocrotaline-induced pulmonary-hypertension in rats Cardiovasc Res 27 1993 1619 1623
40. A. Keegan, I. Morecroft, D. Smillie, M.N. Hicks, and M.R. MacLean Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension - converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935 Circ Res 89 2001 1231 1239
41. H.A. Kluess, J. Stafford, K.W. Evanson, A.J. Stone, J. Worley, and R.F. Wideman Intrapulmonary arteries respond to serotonin and adenosine triphosphate in broiler chickens susceptible to idiopathic pulmonary arterial hypertension Poult Sci 91 2012 1432 1440
42. J.M. Launay, P. Herve, J. Callebert, Z. Mallat, C. Collet, and S. Doly Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension Blood 119 2012 1772 1780
43. A. Lawrie, E. Spiekerkoetter, E.C. Martinez, N. Ambartsumian, W.J. Sheward, and M.R. MacLean Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease Circ Res 97 2005 227 235
44. Y. Liu, M. Li, R.R. Warburton, N.S. Hill, and B.L. Fanburg The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells FASEB J 21 2007 2725 2734
45. Y.L. Liu, W.Y. Ren, R. Warburton, D. Toksoz, and B.L. Fanburg Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells FASEB J 23 2009 2299 2306
46. Y.L. Liu, Y.J. Suzuki, R.M. Day, and B.L. Fanburg Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin Circ Res 95 2004 579 586
47. Y.L. Liu, L. Wei, D.L. Laskin, and B.L. Fanburg Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells Am J Respir Cell Mol Biol 44 2011 548 555
48. L. Long, M.R. MacLean, T.K. Jeffery, I. Morecroft, X.D. Yang, and N. Rudarakanchana Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice Circ Res 98 2006 818 827
49. A.A. Lopes, N.Y. Maeda, A. Almeida, R. Jaeger, M. Ebaid, and D.F. Chamone Circulating platelet aggregates indicative of in-vivo platelet activation in pulmonary-hypertension Angiology 44 1993 701 706
50. W. Lovenber, E. Jequier, and M.A. Sjoerds Tryptophan hydroxylation - measurement in pineal gland brainstem and carcinoid tumor Science 155 1967 217 (-&)
51. R.D. Machado, R. Koehler, E. Glissmeyer, C. Veal, J. Suntharalingam, and M. Kim Genetic association of the serotonin transporter in pulmonary arterial hypertension Am J Respir Crit Care Med 173 2006 793 797
52. M.R. MacLean Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action? Trends Pharmacol Sci 20 1999 490 495
53. M.R. MacLean, and Y. Dempsie Serotonin and pulmonary hypertension - from bench to bedside? Curr Opin Pharmacol 9 2009 281 286
54. M.R. MacLean, and Y. Dempsie The serotonin hypothesis of pulmonary hypertension revisited Adv Exp Med Biol 661 2010 309 322
55. M.R. MacLean, G.A. Deuchar, M.N. Hicks, I. Morecroft, S. Shen, and J. Sheward Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension Circulation 109 2004 2150 2155
56. M.R. MacLean, and I. Morecroft Increased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy Br J Pharmacol 134 2001 614 620
57. E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle, and G. Simonneau Serotonin transporter and receptors in various forms of human pulmonary hypertension Chest 128 2005 552S 553S
58. M.D. Mcgoon, and R.E. Vlietstra Acute hemodynamic-response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary-hypertension Int J Cardiol 14 1987 303 309
59. A. Mekontso-Dessap, F. Brouri, O. Pascal, P. Lechat, N. Hanoun, and L. Lanfumey Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice Circulation 113 2006 81 89
60. I. Morecroft, Y. Dempsie, M. Bader, D.J. Walther, K. Kotnik, and L. Loughlin Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension Hypertension 49 2007 232 236
61. I. Morecroft, L. Pang, M. Baranowska, M. Nilsen, L. Loughlin, and Y. Dempsie In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension Cardiovasc Res 85 2010 593 603
62. I. Morecroft, K. White, P. Caruso, M. Nilsen, L. Loughlin, and R. Alba Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension Mol Ther 2012
63. N.W. Morrell, S. Adnot, S.L. Archer, J. Dupuis, P.L. Jones, and M.R. MacLean Cellular and molecular basis of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S20 S31
64. H.J. Mortimer, A.J. Peacock, A. Kirk, and D.J. Welsh P38 MAP kinase: essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation Pulm Pharmacol Ther 20 2007 718 725
65. T. Nagatomo, M. Rashid, H.A. Muntasir, and T. Komiyama Functions of 5-HT2A receptor and its antagonists in the cardiovascular system Pharmacol Ther 104 2004 59 81
66. L. Piao, Y.H. Fang, V.J.J. Cadete, C. Wietholt, D. Urboniene, and P.T. Toth The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle J Mol Med JMM 88 2010 47 60
67. L. Piao, G. Marsboom, and S.L. Archer Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure J Mol Med JMM 88 2010 1011 1020
68. Press releases, Predix, 7, 16 Aug & 8 Dec 2006 & EPIX, 7 Aug 2007 & 15 May 2008; Form 10-K, EPIX, 2008. 2012. Ref Type: Online Source.
69. L.C. Price, S.J. Wort, F. Perros, P. Dorfmuller, A. Huertas, and D. Montani Inflammation in pulmonary arterial hypertension Chest 141 2012 210 221
70. H.L. Reeve, S.L. Archer, M. Soper, and E.K. Weir Dexfenfluramine increases pulmonary smooth muscle intracellular Ca2+ independent of membrane potential Am J Physiol Lung Cell Mol Physiol 277 1999 L662 L666
71. W. Ren, S.W. Watts, and B.L. Fanburg Serotonin transporter interacts with the PDGFbeta receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol 300 2011 L486 L497
72. G.Y. Rochefort, M.C. Lemaire, V. Eder, G. Hanton, J.M. Hyvelin, and P. Bonnet Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension Eur J Pharmacol 550 2006 149 154
73. R.B. Rothman, M.A. Ayestas, C.M. Dersch, and M.H. Baumann Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates - implications for primary pulmonary hypertension Circulation 100 1999 869 875
74. R.B. Rothman, M.H. Baumann, J.E. Savage, L. Rauser, A. McBride, and S.J. Hufeisen Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications Circulation 102 2000 2836 2841
75. R.B. Rothman, J.L. Cadet, C.M. Dersch, M.T. Mccoy, E. Lehrmann, and K.G. Becker Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension PLoS One 6 2011
76. R.T. Schermuly, E. Dony, H.A. Ghofrani, S. Pullamsetti, R. Savai, and M. Roth Reversal of experimental pulmonary hypertension by PDGF inhibition J Clin Invest 115 2005 2811 2821
77. R.T. Schermuly, H.A. Ghofrani, M.R. Wilkins, and F. Grimminger Mechanisms of disease: pulmonary arterial hypertension Nat Rev Cardiol 8 2011 443 455
78. K. Seuwen, I. Magnaldo, and J. Pouyssegur Serotonin stimulates Dna-synthesis in fibroblasts acting through 5-Ht 1B receptors coupled to A Gi-protein Nature 335 1988 254 256
79. S.J. Shah, M. Gomberg-Maitland, T. Thenappan, and S. Rich Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension Chest 136 2009 694 700
80. L. Shen, J.Y. Shen, J. Pu, and B. He Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels Cell Biochem Biophys 61 2011 23 31
81. E.R. Stephenson, B. Soleimani, C.D. Kline, L.C. Price, C. Brehm, and A. El-Banayosy Incidence of major and minor mechanical driveline failure in continuous flow left ventricular assist devices J Heart Lung Transplant 31 2012 S195
82. M. Toshner, and N.W. Morrell Endothelial progenitor cells in pulmonary hypertension - dawn of cell-based therapy? Int J Clin Pract 64 2010 7 12
83. M. Toshner, R. Voswinckel, M. Southwood, R. Al-Lamki, L.S.G. Howard, and D. Marchesan Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension Am J Respir Crit Care Med 180 2009 780 787
84. I.H. Ulus, T.J. Maher, and R.J. Wurtman Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors Biochem Pharmacol 59 2000 1611 1621
85. D.J. Walther, and M. Bader A unique central tryptophan hydroxylase isoform Biochem Pharmacol 66 2003 1673 1680
86. D.J. Walther, J.U. Peter, S. Bashammakh, H. Hortnagl, M. Voits, and H. Fink Synthesis of serotonin by a second tryptophan hydroxylase isoform Science 299 2003 76
87. H.L. Wang, X. Dong, X.H. Zhang, and J. Xing 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats Acta Pharmacol Sin 22 2001 269 273
88. L. Wei, Y.L. Liu, H. Kaneto, and B.L. Fanburg JNK regulates serotonin-mediated proliferation and migration of pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol 298 2010 L863 L869
89. L. Wei, R.R. Warburton, I.R. Preston, K.E. Roberts, S.A.A. Comhair, and S.C. Erzurum Serotonylated fibronectin is elevated in pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 302 2012 L1273 L1279
90. E.K. Weir, H.L. Reeve, J.M.C. Huang, E. Michelakis, D.P. Nelson, and V. Hampl Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction Circulation 94 1996 2216 2220
91. D.J. Welsh, M. Harnett, M. Maclean, and A.J. Peacock Proliferation and signaling in fibroblasts - role of 5-hydroxytryptamine(2A) receptor and transporter Am J Respir Crit Care Med 170 2004 252 259
92. K. White, A.K. Johansen, M. Nilsen, L. Ciuclan, E. Wallace, and L. Paton Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension Circulation 126 9 2012, Aug 28 1087 1098
93. K. White, L. Loughlin, Z. Maqbool, M. Nilsen, J. McClure, and Y. Dempsie Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH Physiol Genomics 43 2011 417 437
94. E.D. Willers, J.H. Newman, J.E. Loyd, I.M. Robbins, L.A. Wheeler, and M.A. Prince Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 173 2006 798 802
95. M. Yang, K. Li, P.C. Ng, C.K.Y. Chuen, T.K. Lau, and Y.S. Cheng Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34(+) stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis Stem Cells 25 2007 1800 1806
96. E. Ziu, C.P. Mercado, Y.C. Li, P. Singh, B.A. Ahmed, and S. Freyaldenhoven Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin J Mol Cell Cardiol 52 2012 1112 1121